Dr. Torben Skarsfeldt joined FPG in 2010 to augment our capabilities in Northern Europe, especially Scandinavia. Torben brings extensive experience in the pharmaceutical industry, 17 years in Research & Discovery and 13 years of International Business Development.
Most recently Torben was CEO of Pharma Guidance, a small US-based biotech company. From 2004-2009, he was Project Director at Lundbeck, having joined the International Licensing Department in 1997, and becoming Director of Business Development in 2001. He was also a Member of the Lundbeck Supervisory Board from 1990 – 2006.
Torben graduated as a Doctor of Science from Copenhagen University, when he previously received his Master of Science. He is the co-inventor of an antipsychotic drug that has been marketed in 15 countries (Serdolect).